Viewing Study NCT00000751

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-06-16 @ 11:38 PM
Study NCT ID: NCT00000751
Status: COMPLETED
Last Update Posted: 2008-09-30
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Pregnancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pregnancy View
None Pregnancy Complications, Infectious View
None Drug Therapy, Combination View
None Acquired Immunodeficiency Syndrome View
None AIDS-Related Complex View
None Zidovudine View
None Immunoglobulins, Intravenous View
None Immunization, Passive View